异种支架在肩袖全层撕裂修复中的不良效应:一项随机双盲安慰剂对照研究
该随机双盲安慰剂对照试验评估自体间充质干细胞(MSCs)嵌入异种支架修复冈上肌腱的安全性和有效性。MSC治疗组Constant评分较术前显著改善(p=0.0073),但二次结局指标两组相似,结论初步且不确定。
要点
- MSC治疗组Constant评分较术前显著改善(p=0.0073)。
- 二次结局指标两组相似,整体结论初步且不确定。
核心结论
- MSC治疗组临床结局初步但不确定,不良事件提示需改用不同性质支架或不用支架。
研究设计与样本
- 随机、双盲、安慰剂对照试验,评估肩袖全层撕裂患者,注册号Eudra-CT 2007-007630-19。
主要发现
- MSC治疗组Constant问卷较术前显著改善(p=0.0073)。
- 二次结局指标两组相似。
关键数值与推荐
- 主要终点为一年时Constant评分较初始评估改善20分。
- Constant评分总分0(最重残疾)至100(最轻残疾),含疼痛15分、日常生活20分、活动度40分、力量25分。
- 肌腱结构完整性按Patte和Thomazeau分类标准经MRI评估。
临床怎么用
- 异种支架在小关节修复中可能带来不良效应,需谨慎评估。
- MSC联合异种支架的临床获益尚不确定,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of the study was to compare the safety and efficacy of autologous mesenchymal stem cells (MSCs) embedded in a xenogenic scaffold for repairing the supraspinatus tendon. METHODS: This was a randomized, double-blind and placebo-controlled trial evaluating patients with full-thickness rotator cuff tears (Eudra-CT, 2007-007630-19). Effectiveness was evaluated using the Constant score and a visual analogue pain scale (VAS). Constant score has four domains including pain (15 possible points), activities of daily living (20 possible points), mobility (40 possible points), and strength (25 possible points). Scores range from 0 points (most disability) to 100 points (least disability). The structural integrity of the repaired tendon was assessed by magnetic resonance imaging (MRI) according to Patte and Thomazeau classification criteria. The primary study end point was an improvement in the Constant score by 20 points at one year compared to initial assessment. RESULTS: The trial was stopped due to adverse effects observed in both groups. Only thirteen patients were included and analyzed. The Constant questionnaire showed a significant improvement in the MSC treatment group compared with the preoperative data (p = 0.0073). Secondary outcome measures were similar in both groups. CONCLUSIONS: Our study showed preliminary inconclusive clinical outcomes in the patients treated with MSCs. Adverse events revealed the need for further approaches using scaffolds of a different nature or perhaps no scaffolds, in the context of small joints. TRIAL REGISTRATION: Eudra-CT, 2007-007630-19 . Registered on 30 January 2008. LEVEL OF EVIDENCE: A Level 1 of evidence treatment study.
引用
- Lamas JR, García-Fernández C, Tornero-Esteban P, et al. Adverse effects of xenogenic scaffolding in the context of a randomized double-blind placebo-controlled study for repairing full-thickness rotator cuff tears. Trials. 2019. PMID: 31262366. doi:10.1186/s13063-019-3504-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。